HomeKPL › Filing
🔔 Get instant alerts when KPL files quarterly results on BSE Start free trial →

Proceedings of 43rd Annual General Meeting attached herewith.

Filed: 31 Aug 2026, 18:27 IST Exchange: BSE Category: General Update — AGM Proceedings
Proceedings of 43rd Annual General Meeting held on August 31, 2026 via VC/OAVM - Quorum of 34 members present - Financial statements for FY25-26 considered and adopted - Re-appointment of directors Mr. Aditya Arora and Mrs. Anju Arora approved - Appointment of Mr. Swanith Kapoor as Independent Director approved - Remuneration of Whole Time Director Mr. Aditya Arora approved - Cost Auditors remuneration ratified - E-voting conducted from Aug 28 to Aug 31, 2026 - Scrutinizer to submit consolidated voting results within two working days
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 KPL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add KPL to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Kwality Pharmaceuticals Limited

Important. The summary above is generated automatically from Kwality Pharmaceuticals Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.